Husky_Chinaplas
Husky Injection Moulding Systems, which recently completed the acquisition of mould-maker Schöttli, is showcasing mould technology for specific medical and specialty closure application at Chinaplas.
“Chinaplas has always been an important show for Schöttli and we are very excited to be exhibiting this year together with Husky,” said Thomas Anderegg, President of the Schöttli Group.
“Asia Pacific is a growing market, particularly for medical moulds, and we are looking forward to the opportunity to connect with our customers in this region and demonstrate the combined capabilities of Schöttli and Husky.”
Applications on display include syringes, infusion/transfusion products, diagnostic systems and feminine care items. Also featured will be Husky’s EASYcube mould technology, a platform for moulding multi-material closures.